MS

Manjula Sukapala

Active Director Director DIN 09452670
DIN 09452670 First appointment Dec 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Manjula Sukapala

Data last updated:

Manjula Sukapala is a Director at Hmab Formulations Private Limited (since 2021). The company operates in Pharma.

DIN 09452670
Primary Designation Director
Industry Pharma
First Appointment 30 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hmab Formulations Private Limited U24299TG2021PTC158377
Director30 Dec 20212021Active

Board colleagues of Manjula Sukapala

Directorship timeline

Open interactive timeline →
Hmab Formulations Private Limited
Premium access

Shareholding and investment profile for Manjula Sukapala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manjula Sukapala

Manjula Sukapala currently holds 1 directorship: Hmab Formulations Private Limited (Director, since 30 Dec 2021).

Manjula Sukapala was first appointed on 30 Dec 2021 as Director at Hmab Formulations Private Limited.

The current boards of Manjula Sukapala's companies include Anusree Vallabhaneni (Hmab Formulations Private Limited), Vishnu Kiran Meka (Hmab Formulations Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available